The Potential of a New Nomogram for the Diagnosis of Primary Aldosteronism

Overview

Journal Hypertens Res

Specialty Cardiology & Vascular Diseases

Date 2023 Aug 15

PMID 37582851

Authors

Tatsuya Haze

Affiliations

Soon will be listed here.

References

Haze T, Ozawa M, Kawano R, Haruna A, Ohki Y, Suzuki S . Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism. Hypertens Res. 2023; 46(5):1132-1144. DOI: 10.1038/s41440-023-01170-9. View

Haze T, Hatakeyama M, Komiya S, Kawano R, Ohki Y, Suzuki S . Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism. Hypertens Res. 2021; 44(10):1341-1351. PMC: 8490149. DOI: 10.1038/s41440-021-00719-w. View

Neves M, Cunha A, Cunha M, Gismondi R, Oigman W . The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging. High Blood Press Cardiovasc Prev. 2018; 25(2):137-145. DOI: 10.1007/s40292-018-0252-5. View

Morita R, Azushima K, Sunohara S, Haze T, Kobayashi R, Kinguchi S . High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism. Hypertens Res. 2023; 46(8):1995-2004. DOI: 10.1038/s41440-023-01325-8. View

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y . Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Hypertension. 2018; 71(3):530-537. DOI: 10.1161/HYPERTENSIONAHA.117.10263. View

Fernandez-Argueso M, Pascual-Corrales E, Bengoa Rojano N, Garcia Cano A, Jimenez Mendiguchia L, Araujo-Castro M . Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study. Endocrine. 2021; 73(2):439-446. DOI: 10.1007/s12020-021-02704-2. View

Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H . Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis. 2021; 324:84-90. DOI: 10.1016/j.atherosclerosis.2021.03.033. View

Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H . Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function. J Hum Hypertens. 2021; 36(10):904-910. DOI: 10.1038/s41371-021-00595-4. View

Yamashita T, Shimizu S, Koyama M, Ohno K, Mita T, Tobisawa T . Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K. J Hypertens. 2017; 36(2):326-334. DOI: 10.1097/HJH.0000000000001511. View

10.

Hung A, Ahmed S, Gupta A, Davis A, Kline G, Leung A . Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism. J Clin Endocrinol Metab. 2021; 106(8):2423-2435. DOI: 10.1210/clinem/dgab348. View